Neovacs and Stellar Biotechnologies sign joint venture agreement to create Neostell SAS
PARIS and BOSTON, May 12, 2016 (GLOBE NEWSWIRE) -- Neovacs (Alternext Paris:ALNEV) a leader in active immunotherapy for the treatment of autoimmune diseases, today announced that the Company has finalized the terms of its partnership with US company …